The Cardio Vascular Clinical Trialists Forum (CVCT) serves as a unique think tank, focusing on the latest critical trials in the fields of CardioVascular, CardioRenal, and Cardiometabolic health. It provides a platform for authoritative stakeholders to spend hours delving into individual trials, examining them both individually and in context. The forum aims to foster collaboration, brainstorming, and knowledge-sharing among key clinical trial players.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.